Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - Rich Pharmaceuticals, Inc. | Financial_Report.xls |
10-K - MAINBODY - Rich Pharmaceuticals, Inc. | mainbody.htm |
EX-31.1 - EXHIBIT 31.1 - Rich Pharmaceuticals, Inc. | ex31_1.htm |
EX-31.2 - EXHIBIT 31.2 - Rich Pharmaceuticals, Inc. | ex31_2.htm |
EX-32.1 - EXHIBIT 32.1 - Rich Pharmaceuticals, Inc. | ex32_1.htm |
Silberstein Ungar, PLLC CPAs and Business Advisors
Phone (248) 203-0080
Fax (248) 281-0940
30600 Telegraph Road, Suite 2175
Bingham Farms, MI 48025-4586
www.sucpas.com
June 27, 2012
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Board of Directors
Nepia, Inc.
Shenzhen, China
To Whom It May Concern:
Silberstein Ungar, PLLC hereby consents to the use in the Form Form 10-K, Annual Report under Section 13 or 15(d) of the Securities Exchange Act of 1934, filed by Nepia, Inc. of our report dated June 22, 2012, relating to the financial statements of Nepia, Inc., as of and for the periods ending March 31, 2012 and 2011, and for the period from August 9, 2010 (date of inception) to March 31, 2012.
Sincerely,
/s/ Silberstein Ungar, PLLC
Silberstein Ungar, PLLC
Bingham Farms, Michigan